Drug
Azvudine clinical trials
Also written FNC.
- studies test it
- 17
- open now
- 3
- in phase 3
- 6
- first study started
- 2020
Keep track of what changes. Save the azvudine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2022 (6)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 3
- Phase 3
- 6
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 6
Henan Genuine Biotech Co., Ltd. (8) · HRH Pharmaceuticals Limited (2) · Shanghai Henlius Biotech (2) · Zhigang Ren (1) · Peking Union Medical College Hospital (1) · Shandong Provincial Hospital (1) · Southeast University, China (1) · HeNan Sincere Biotech Co., Ltd (1)
Often tested with
Tested in the same studies.
Lopinavir-ritonavir drug combination (1) · Dolutegravir (1) · Itraconazole (1) · Rifampin (1) · Rilpivirine (1)
Studies
Open first, then newest update. How each study uses azvudine is read from its arms, and is right about nine times in ten.
Testing it · 17
- A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis BRecruitingPhase 3Zhigang RenNCT07307586Written as AZVUDINE
- A Pharmacokinetics and Safety Study of Azvudine Tablets in Subjects With Mild-To-Moderate GFR Decline in Renal Insufficiency and in Healthy SubjectsRecruitingPhase 1Henan Genuine Biotech Co., Ltd.NCT07001436Written as Azvudine tablets
- Multicenter Randomized Double-blind Placebo-controlled Study to Investigate Azvudine in Symptomatic Adults With COVID-19 at Increased Risk of Progressing to Severe IllnessRecruitingPhase 2/3Peking Union Medical College HospitalNCT05689034Written as Azvudine
- A Study to Evaluate the Pharmacokinetics and Safety of Azvudine Tablets in Healthy Adult Subjects and Healthy Elderly SubjectsCompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT06991634Written as Azvudine tablets
- A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and AluviaCompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07002242Written as Azvudine tablets(FNC) and Aluvia
- A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Dolutegravir Sodium Tablets (DTG)CompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07002229Written as Azvudine tablets(FNC) and Dolutegravir Sodium Tablets (DTG)
- A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Itraconazole Capsules (ICZ)CompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07001501Written as Azvudine tablets(FNC) and Itraconazole Capsules (ICZ)
- [14C] Mass Balance Clinical Trial of Azvudine in Healthy Male SubjectsCompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07002281Written as [14C]Azvudine suspension
- A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rifampicin Capsules (RIF)CompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07002255Written as Azvudine tablets(FNC) and Rifampicin Capsules (RIF)
- A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Rilpivirine Tablets (RPV)CompletedPhase 1Henan Genuine Biotech Co., Ltd.NCT07001488Written as Azvudine tablets(FNC) and Rilpivirine Tablets (RPV)
- A Study of Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 InfectionStatus unknownPhase 4Shandong Provincial HospitalNCT05697055Written as Azvudine
- Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in ChinaStatus unknownPhase 2Shanghai Henlius BiotechNCT05682599Written as Azvudine
- Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19Status unknownPhase 2/3Shanghai Henlius BiotechNCT05633433Written as Azvudine
- The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled TrialStatus unknownNot applicableSoutheast University, ChinaNCT05642910Written as Azvudine
- Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)CompletedPhase 3HRH Pharmaceuticals LimitedNCT04668235Written as AZVUDINE
- Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)CompletedPhase 3HRH Pharmaceuticals LimitedNCT05033145Written as AZVUDINE
- Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive PatientsStatus unknownPhase 3HeNan Sincere Biotech Co., LtdNCT04303598Written as FNC
Codes
What other systems call azvudine · ClinicalTrials.gg INT005439
- MeSH (NLM) C540945azvudineOne source NLM
- UNII (FDA) IJ2XP0ID0KAZVUDINEConfirmed FDA, NLM, Wikidata
- Wikidata Q88266928azvudineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C221863AzvudineOne source FDA
- DrugBank DB16407One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C540945 | azvudine | One source NLM |
| UNII (FDA) | IJ2XP0ID0K | AZVUDINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q88266928 | azvudine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C221863 | Azvudine | One source FDA |
| DrugBank | DB16407 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.